Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases

The occurrence of brain metastases among breast cancer patients is currently rising with approximately 20–25% incidence rates, underlining the importance of the identification of new therapeutic and prognostic markers. We have previously screened for new markers for brain metastasis by array CGH. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Wikman, Harriet, Sielaff-Frimpong, Bettina, Kropidlowski, Jolanthe, Witzel, Isabell, Milde-Langosch, Karin, Sauter, Guido, Westphal, Manfred, Lamszus, Katrin, Pantel, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485301/
https://www.ncbi.nlm.nih.gov/pubmed/23118876
http://dx.doi.org/10.1371/journal.pone.0047537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485301/
https://www.ncbi.nlm.nih.gov/pubmed/23118876
http://dx.doi.org/10.1371/journal.pone.0047537

Ejemplares similares